会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • TRIPEPTIDE DERIVATIVE ANTI-INFLAMMATORY AGENTS
    • TRIPEPTIDE衍生抗炎剂
    • WO1993008211A1
    • 1993-04-29
    • PCT/US1992008901
    • 1992-10-19
    • THE PROCTER & GAMBLE COMPANY
    • THE PROCTER & GAMBLE COMPANYMcIVER, John, McMillan
    • C07K05/06
    • C07K5/06191A61K38/00C07K5/06034C07K5/06043C07K5/06052C07K5/0606C07K5/06078C07K5/06086
    • The subject invention involves anti-inflammatory compounds having structure (1), wherein (a) n is an integer of from 0 to about 2; (b) -R is selected from straight or branched alkyl, saturated or unsaturated with 1 or 2 double bonds, having from 1 to about 6 carbon atoms; and cyclic alkyl, saturated or unsaturated with 1 or 2 double bonds, having from 3 to about 13 carbon atoms; and the carbon atom to which -R is bonded is in either D or L configuration; (c) -R' is selected from branched alkyl, saturated or unsaturated with 1 or 2 double bonds, having from 3 to about 6 carbon atoms; cyclic alkyl, saturated or unsaturated with 1 or 2 double bonds, having from 3 to about 13 carbon atoms; and arylalkyl, the alleyl portion being saturated and having from 1 to about 3 carbon atoms; and the carbon atom to which -R' is bonded is in L configuration; (d) -R'' is -(CH2)m-A-NH2 or -(CH2)m-A-B-C(NH2)=NH, wherein m is an integer of from 1 to about 5; -A- is a covalent bond, or p-phenyl or p-cyclohexyl; and -B- is a covalent bond or -NH-; and the carbon atom to which -R'' is bonded is in L configuration; (e) -Y is hydrogen or trifluoromethyl; (f) -Z- is -O- or -NH-; (g) -V- is selected from -OC(O)-, -N(Q)C(O)-, -N(Q)C(S)-, -C(O)-, -SO2- and -P(O)(OH)-; when -V- is -OC(O)-, -Z- is -NH-; (h) -X is selected from the group consisting of cyclic alkyl, branched alkyl having at least two branches, and aryl, each having from 5 to about 20 carbon atoms; and (i) -Q is selected from the group consisting of hydrogen; and straight or branched chain alkyl, saturated or unsaturated with 1 or 2 double bonds, having from 1 to about 6 carbon atoms; or -Q and -X are covalently linked forming a cyclic moiety which includes the nitrogen to which -Q is bonded and from 5 to about 20 carbon atoms. The subject invention also involves pharmaceutical compositions comprising the above compounds, and methods for treating inflammation or pain using such compounds and compositions.
    • 本发明涉及具有结构(1)的抗炎化合物,其中(a)n为0至约2的整数; (b)-R选自具有1至约6个碳原子的具有1或2个双键的饱和或不饱和的直链或支链烷基; 具有3至约13个碳原子的具有1或2个双键的饱和或不饱和环状烷基; R结合的碳原子为D或L构型; (c)-R'选自具有3至约6个碳原子的具有1或2个双键的饱和或不饱和的支链烷基; 具有3至约13个碳原子的具有1或2个双键的饱和或不饱和环状烷基; 和芳基烷基,所述烷基部分是饱和的且具有1至约3个碳原子; 且R'键合的碳原子为L构型; (d)-R“是 - (CH 2)m -A-NH 2或 - (CH 2)m -A-B-C(NH 2)= NH,其中m是1至约5的整数; -A-是共价键,或对 - 苯基或对 - 环己基; 和-B-是共价键或-NH-; 并且与R“结合的碳原子为L构型; (e)-Y是氢或三氟甲基; (f)-Z-是-O-或-NH-; (O) - , - N(Q)C(O) - , - N(Q)C(S) - , - (O) - , - SO 2 - 呸)-; 当-V-为-OC(O) - 时,-Z-为-NH-; (h)-X选自具有至少两个分支的环烷基,支链烷基和具有5至约20个碳原子的芳基; 和(i)-Q选自氢; 和具有1至约6个碳原子的具有1或2个双键的饱和或不饱和的直链或支链烷基; 或-Q和-X共价连接形成环状部分,其包括与Q键合的氮和5至约20个碳原子。 本发明还涉及包含上述化合物的药物组合物,以及使用这些化合物和组合物治疗炎症或疼痛的方法。